References: 

• 1. Kaiser Health News, Medicare To Penalize 2,217 Hospitals For Excess Re-admissions, 2016. Available from: https://khn.org/news/medicare-hospitals-readmissions-penalties/.
• 2. CMS.gov Centers for Medicare & Medicaid Services, Hospital Re-admissions-Reduction-Program, 2017. Available from: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html.
• 3. Miller DE, Roane TE, Mclin KD (2016) Reduction of 30-Day hospital re-admissions after patient-centric telephonic medication therapy management services. Hosp Pharm 51: 907–914.    
• 4. Li H, Guffey W, Honeycutt L, et al. (2016) Incorporating a pharmacist into the discharge process: A unit-based transitions of care pilot. Hosp Pharm 51: 744–751.    
• 5. Arnold ME, Buys L, Fullas F (2015) Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on re-admission rate. Am J Health-Syst Ph 72: 36–42.
• 6. Ravn-Nielsen LV, Duckert ML, Lund ML, et al. (2018) Effect of In-Hospital multifaceted clinical pharmacist intervention on re-admission, JAMA Intern Med 178: 375–382.
• 7. Ni W, Colayco D, Hashimoto J, et al. (2018) Reduction of healthcare costs through a transitions-of-care program. Am J Health Syst Pharm 75: 613–621.    
• 8. Tedesco GW, Mcconaha JL, Skomo ML, et al. (2016) A pharmacist's impact on 30-Day re-admission rates when compared to the current standard of care within a patient-centered medical home. J Pharm Pract 29: 368–373.    
• 9. Lisenby KM, Carroll DN, Pinner NA (2015) Evaluation of a pharmacist-specific intervention on 30-Day re-admission rates for high-risk patients with pneumonia. Hosp Pharm 50: 700–709.    
• 10. Gasbarro NM, Eginger KH, Street C (2014) Impact of clinical pharmacist interventions on 30-Day re-admission rate in hospitalized patients with acute myocardial infarction. J Pharm Technol 31: 64–68.
• 11. Warden BA, Freels JP, Furuno JP, et al. (2014) Pharmacy-managed program for providing education and discharge instructions for patients with heart failure. Am J Health-Syst Ph 71: 134–139.    
• 12. Shull MT, Braitman LE, Stites SD, et al. (2018) Effects of a pharmacist-driven intervention program on hospital re-admissions. Am J Health-Syst Ph 75: 221–230.    
• 13. Mekonnen AB, Mclachlan AJ, Brien JE (2016) Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: A systematic review and meta-analysis. BMJ Open 6: e010003.    
• 14. Ballard J, Rankin W, Roper KL, et al. (2018) Effect of ambulatory transitional care management on 30-Day re-admission rates. Am J Med Qual 33: 583–589.    
• 15. Murphy JA, Schroeder MN, Rarus RE, et al. (2017) Implementation of a cardiac transitions of care pilot program: A prospective study of inpatient and outpatient clinical pharmacy services for patients with heart failure exacerbation or acute myocardial infarction. J Pharm Pract 32: 68–76.
• 16. Lone NI, Lee R, Salisbury L, et al. (2018) Predicting risk of unplanned hospital re-admission in survivors of critical illness: A population-level cohort study. Thorax: pii: thoraxjnl-2017-210822.
• 17. Mudge AM, Shakhovskoy R, Karrasch A (2013) Quality of transitions in older medical patients with frequent re-admissions: Opportunities for improvement. Eur J Intern Med 24: 779–783.    
• 18. Groesbeck K, Whiteman LN, Stewart RW (2015) Reducing re-admission rates by improving transitional care. South Med J 108: 758–760.    
• 19. Kerstenetzky L, Heimerl LM, Hartkopf KJ, et al. (2018) Inpatient pharmacists' patient referrals to a transitions-of-care pharmacist: Evaluation of an automated referral process. J Am Pharm Assoc 58: 540–546.    
• 20. Gil M, Mikaitis DK, Shier G, et al. (2013) Impact of a combined pharmacist and social worker program to reduce hospital re-admissions. J Manag Care Pharm 19: 558–563.
• 21. Phatak A, Prusi R, Ward B, et al. (2015) Impact of pharmacist involvement in the transitional care of high-risk patients through medication reconciliation, medication education, and postdischarge call-backs (IPITCH Study). J Hosp Med 111: 39–44.
• 22. Stranges PM, Marshall VD, Walker PC, et al. (2015) A multidisciplinary intervention for reducing re-admissions among older adults in a patient-centered medical home. Am J Manag Care 21: 106–113.
• 23. Kamermayer AK, Leasure AR, Anderson L (2017) The effectiveness of transitions-of-care interventions in reducing hospital Re-admissions and mortality. Dimens Crit Care Nurs 36: 311–316.    
• 24. Kennelty KA, Chewning B, Wise M, et al. (2015) Barriers and facilitators of medication reconciliation processes for recently discharged patients from community pharmacists' perspectives. Res Social Adm Pharm 11: 517–530.    
• 25. Yang S (2017) Impact of pharmacist-led medication management in care transitions. BMC Health Serv Res 17: 722.    
• 26. Ni W, Colayco D, Hashimoto J, et al. (2017) Impact of a pharmacy-based transitional care program on hospital readmissions. Am J Manag Care 23: 170–176.
• 27. Jackson C, Shahsahebi M, Wedlake T, et al. (2015) Timeliness of outpatient follow-up: An evidence-based approach for planning after hospital discharge. Ann Fam Med 13: 115–122.    
• 28. Hamar B, Rula EY, Wells AR, et al. (2016) Impact of a scalable care transitions program for re-admission avoidance. Am J Manag Care 22: 28–34.
• 29. Hansen LO, Young RS, Hinami K, et al. (2011) Interventions to reduce 30-Day rehospitalization: A systematic review. Ann Intern Med 155: 520–528.    
• 30. Brand CA, Jones CT, Lowe AJ, et al. (2004) A transitional care service for elderly chronic disease patients at risk of re-admission. Aust Health Rev 28: 275–284.    
• 31. Jones CD, Anthony A, Klein MD, et al. (2018) The effect of a pharmacist-led multidisciplinary transitions-of-care pilot for patients at high risk of re-admission. J Am Pharm Assoc 58: 554–560.    

show all references